The Efficacy and Safety of Revefenacin for the Treatment of Chronic Obstructive Pulmonary Disease: A Systematic Review

• Principais autores: Jiaxing Zhang (Autor), Yihong Xie (Autor), Joey Sum-wing Kwong (Autor), Long Ge (Autor), Rui He (Autor), Wenyi Zheng (Autor), Jing Han (Autor), Rui Zhang (Autor), Huaye Zhao (Autor), Yuru He (Autor), Xiaosi Li (Autor)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2021-10-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Background Revefenacin (REV) is a novel once-daily long-acting muscarinic antagonist (LAMA) in the treatment of moderate to very severe chronic obstructive pulmonary disease (COPD). This systematic review incorporating a dose-response meta-analysis aimed to assess the efficacy and safety of REV.Meth...